University of Birmingham's cancer immunotherapy developer Revitope Oncology secured equity funding as part of a $160m alliance with Junshi Biosciences.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Gilead Sciences will invest $275m for a 49.9% stake in the UofT and UCSF-linked company as part of a $1.47bn deal to potentially purchase Pionyr outright.

The carmaker has followed up a $100m investment two years ago with a pledge to provide up to $200m for the Stanford-originated solid-state battery developer.

Eli Lilly will collaborate on five drug candidates based on the Oxford and Karolinska Institute spinout's exosome delivery technology.

Woodford has faced challenges in selling its shareholdings in spinouts including Oxford Nanopore and Immunocore, but has now lined up Acacia as a potential buyer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

More than six years after being launched by Open University to offer massive open online courses, FutureLearn has raised its first external funding from Seek Group.

Asklepios BioPharmaceutical, based on work by UNC Chapel Hill professors Jude Samulski and Xiao Xiao, has secured $235m in funding co-led by TPG Capital and Vida Ventures.

Meyer Burger picked up an 18% share in solar film manufacturing spinout Oxford PV, following a recent $41m first series D close for the spinout.